Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -127,119 | -83,150 | -46,606 | -240,053 | -155,022 |
| Depreciation Amortization | 2,483 | 1,681 | 843 | 3,267 | 2,420 |
| Income taxes - deferred | N/A | N/A | N/A | 37,104 | -5,750 |
| Accounts receivable | 1,058 | 2,314 | 1,995 | 47,789 | 51,787 |
| Accounts payable and accrued liabilities | -1,217 | -6,083 | -1,247 | 3,173 | -3,398 |
| Other Working Capital | -6,201 | -14,742 | -9,923 | 44,271 | 37,469 |
| Other Operating Activity | 29,013 | 23,040 | 10,843 | -14,237 | -14,559 |
| Operating Cash Flow | $-101,983 | $-76,940 | $-44,095 | $-118,686 | $-87,053 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -777 | -561 | -531 | -3,216 | -2,889 |
| Investing Cash Flow | $-777 | $-561 | $-531 | $-3,216 | $-2,889 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 98,174 | 61,805 | 356 | 773 | 774 |
| Other Financing Activity | 0 | 37,248 | 0 | 73,102 | 73,102 |
| Financing Cash Flow | $98,174 | $99,053 | $356 | $73,875 | $73,876 |
| Exchange Rate Effect | 260 | -31 | -43 | 184 | 32 |
| Beginning Cash Position | 278,598 | 278,598 | 278,598 | 326,441 | 326,441 |
| End Cash Position | 274,272 | 300,119 | 234,285 | 278,598 | 310,407 |
| Net Cash Flow | $-4,326 | $21,521 | $-44,313 | $-47,843 | $-16,034 |
| Free Cash Flow | |||||
| Operating Cash Flow | -101,983 | -76,940 | -44,095 | -118,686 | -87,053 |
| Capital Expenditure | -777 | -561 | -531 | -3,216 | -2,889 |
| Free Cash Flow | -102,760 | -77,501 | -44,626 | -121,902 | -89,942 |